Evidence map›Paper›PMID 31907030›Full record

ArticleWorld journal of surgical oncology2020

Ex vivo resection and temporary portocaval shunt of unresectable hepatocellular carcinoma followed by autotransplantation of liver: a case report.

Hesameddin Eghlimi, Peyman Arasteh, Alireza Shamsaeefar, Hamed Nikopour, Sahar Sohrabi, Saman Nikeghbalian

Open access · goldAbstract readCase Reports
In one paragraph

Article in World journal of surgical oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hesameddin EghlimiShiraz Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Peyman ArastehShiraz Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Alireza ShamsaeefarShiraz Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Hamed NikopourShiraz Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Sahar SohrabiShiraz Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Saman NikeghbalianShiraz Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. shiraz.livertransplantation@gmail.com.
Shiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEx situ liver resection and autotransplantation is among the most advanced techniques which has been introduced in recent years. CASE PRESENTATION: A 24-year-old male referred with chief complaints of abdominal pain, nausea, and vomiting from 1 month prior to admission. Computed tomography showed a large liver mass in the left lobe of the liver with involvement of retrohepatic inferior vena cava (IVC), in favor of hepatocellular carcinoma. After hepatectomy, the common bile duct was completely removed. A 4-cm Dacron graft was anastomosed to the inferior and top of the IVC. A temporary portocaval shunt was placed, and ex situ resection of the left lobe of the liver was done. Remnant of the liver was implanted. Reconstruction of the bile duct was done using a Roux-en-Y technique, and autotransplantation of the liver was then completed. During a 4-year follow-up, the patient had no complaints and is in good conditions.

conclusionWith appropriate consideration of patients, despite surgical complexities, ex situ resection of unresectable HCC can provide excellent prognosis.

Indexed as

AdultCarcinoma, HepatocellularHepatectomyHumansLiver NeoplasmsLiver TransplantationMalePortacaval Shunt, SurgicalPrognosisTransplantation, AutologousVena Cava, InferiorYoung AdultAutotransplantationEx vivoHepatocellular carcinomaResection

Identifiers

PMID31907030
PMCPMC6945702
OpenAlexW3013997246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.